The big news today is that Proteon Therapeutics Inc (NASDAQ:PRTO) has received Breakthrough Designation from the FDA for Vonapanitase, an investigational drug that may …
Proteon Therapeutics Inc (NASDAQ:PRTO) investors are wildly disappointed today amid the firm’s Phase 3 sunken ship for its sole drug contender vonapanitase, sending …
Achaogen Inc (NASDAQ:AKAO) investors are partying around after the company announced surprisingly positive results from both Phase 3 trials of plazomicin in CRE …
Tuesday turned out to be a nightmare for shareholders of Proteon Therapeutics Inc (NASDAQ:PRTO), after the company released data for its failed chronic kidney disease …
